NCT00318721

Brief Summary

A cluster-randomized vector control trial in Bihar, India, and neighboring Nepal, will test the efficacy of long-lasting impregnated bednets (LLINs, Permanets) for reducing visceral leishmaniasis incidence. The intervention unit is the village (400-1000 people). The study is designed to detect a 50% reduction in Leishmania donovani incidence in intervention compared to control clusters over 2 years. 24 clusters (selected as high incidence during previous years) will be randomly allocated to intervention or control. Following health education, and with informed consent, all households in intervention villages will receive free Permanets (from September 2006). Net usage will be monitored and new nets provided if required. Control villages will not be given untreated nets, as - although commonly used in this region - their effectiveness against sandflies has not been proven. Pre-intervention infection status of villagers (\>2 yrs) will be evaluated serologically from finger-prick blood (and past/current disease status noted). Incident infections will be recorded by 3-monthly active search for clinical cases, and by annual serological diagnoses to detect subclinical infections. All villagers (\>2yrs) will be leishmanin skin tested at the end of the trial for further subclinical infection detection, and sera from a sub-sample will be tested for antibodies to sandfly saliva antigens (a measure of sandfly exposure). All clinical cases will be given free treatment. Free Permanets will be provided to control villages after the trial. Complementary studies involve entomological surveillance by light traps in a sample of houses and social/economic questionnaire surveys. The entomological surveys will test whether community-wide use of LLINs provides any mass effect, which could protect those in the community who fail to use LLIN for any reason.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2006

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 27, 2006

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2006

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

November 4, 2009

Status Verified

June 1, 2009

Enrollment Period

2.5 years

First QC Date

April 25, 2006

Last Update Submit

November 3, 2009

Conditions

Keywords

Leishmania donovanicluster-randomised control trialLong Lasting Impregnated NetsBednetsSandflies

Outcome Measures

Primary Outcomes (1)

  • L. donovani infection

    yearly

Secondary Outcomes (1)

  • Kala Azar cases

    quarterly

Study Arms (2)

Intervention

EXPERIMENTAL
Device: Long Lasting Impregnated Nets (LLIN)

control

NO INTERVENTION
Device: Long Lasting Impregnated Nets (LLIN)

Interventions

Distribution of LLIN in selected clusters

Interventioncontrol

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • at least have seen 1 case per year in each of the last 3 years
  • An average of at least 1% Incidence rate over the period of past 3 years.

You may not qualify if:

  • Minimum 500 people
  • Maximum 2000 people
  • Distance between clusters 2000 meters (distance between borders)
  • Houses in tola/ward not sprayed (DDT, other) in 2006
  • Accessibility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kala Azar Medical Research Center

Muzaffarpur, Bihar, India

Location

B P Koirala Institute of Health Sciences

Dharān, Nepal

Location

Related Publications (1)

  • Picado A, Das ML, Kumar V, Kesari S, Dinesh DS, Roy L, Rijal S, Das P, Rowland M, Sundar S, Coosemans M, Boelaert M, Davies CR. Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis. 2010 Jan 26;4(1):e587. doi: 10.1371/journal.pntd.0000587.

MeSH Terms

Conditions

Leishmaniasis, Visceral

Condition Hierarchy (Ancestors)

LeishmaniasisEuglenozoa InfectionsProtozoan InfectionsParasitic DiseasesInfectionsVector Borne Diseases

Study Officials

  • Marleen Boelaert, Dr

    Prince Leopold Institute of Tropical Medicine in Antwerp (ITM), Belgium

    PRINCIPAL INVESTIGATOR
  • Clive Davies, Dr.

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR
  • Jean Claude Dujardin, Dr

    Prince Leopold Institute of Tropical Medicine in Antwerp (ITM), Belgium

    PRINCIPAL INVESTIGATOR
  • Suman Rijal, Dr.

    B.P. Koirala Institute of Heath Sciences, Nepal

    PRINCIPAL INVESTIGATOR
  • Shyam Sundar, Dr

    Institute of Medical Sciences of the Banaras Hindu University, India

    PRINCIPAL INVESTIGATOR
  • Francois Chappuis, Dr.

    University Hospital, Geneva

    PRINCIPAL INVESTIGATOR
  • Beena Varghese, Dr

    Centre for Health and Population Research (ICDDR,B), Dhaka, Bangladesh

    PRINCIPAL INVESTIGATOR
  • Marc Coosemans, Dr

    Prince Leopold Institute of Tropical Medicine in Antwerp (ITM), Belgium.

    PRINCIPAL INVESTIGATOR
  • Veerle Vanlerberghe, Dr.

    Prince Leopold Institute of Tropical Medicine in Antwerp (ITM), Belgium.

    PRINCIPAL INVESTIGATOR
  • Diwarkar Dinesh, Dr

    Rajendra Memorial Research Institute of Medical Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 25, 2006

First Posted

April 27, 2006

Study Start

June 1, 2006

Primary Completion

December 1, 2008

Study Completion

November 1, 2009

Last Updated

November 4, 2009

Record last verified: 2009-06

Locations